Article Details
Retrieved on: 2021-07-23 14:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
There are several bispecific monoclonal antibodies in development for relapsed/refractory DLBCL. These antibodies are aimed to target not only the B ...
Article found on: www.targetedonc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here